Cargando…
Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders
BACKGROUND: In order to optimally integrate the use of high-throughput sequencing (HTS) as a tool in clinical diagnostics of likely monogenic disorders, we have created a multidisciplinary “Genome Clinic Task Force” at the University Hospitals of Geneva, which is composed of clinical and molecular g...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924303/ https://www.ncbi.nlm.nih.gov/pubmed/27353043 http://dx.doi.org/10.1186/s40246-016-0080-4 |
_version_ | 1782439846864748544 |
---|---|
author | Fokstuen, S. Makrythanasis, P. Hammar, E. Guipponi, M. Ranza, E. Varvagiannis, K. Santoni, F. A. Albarca-Aguilera, M. Poleggi, M. E. Couchepin, F. Brockmann, C. Mauron, A. Hurst, S. A. Moret, C. Gehrig, C. Vannier, A. Bevillard, J. Araud, T. Gimelli, S. Stathaki, E. Paoloni-Giacobino, A. Bottani, A. Sloan-Béna, F. Sizonenko, L. D’Amato Mostafavi, M. Hamamy, H. Nouspikel, T. Blouin, J. L. Antonarakis, S. E. |
author_facet | Fokstuen, S. Makrythanasis, P. Hammar, E. Guipponi, M. Ranza, E. Varvagiannis, K. Santoni, F. A. Albarca-Aguilera, M. Poleggi, M. E. Couchepin, F. Brockmann, C. Mauron, A. Hurst, S. A. Moret, C. Gehrig, C. Vannier, A. Bevillard, J. Araud, T. Gimelli, S. Stathaki, E. Paoloni-Giacobino, A. Bottani, A. Sloan-Béna, F. Sizonenko, L. D’Amato Mostafavi, M. Hamamy, H. Nouspikel, T. Blouin, J. L. Antonarakis, S. E. |
author_sort | Fokstuen, S. |
collection | PubMed |
description | BACKGROUND: In order to optimally integrate the use of high-throughput sequencing (HTS) as a tool in clinical diagnostics of likely monogenic disorders, we have created a multidisciplinary “Genome Clinic Task Force” at the University Hospitals of Geneva, which is composed of clinical and molecular geneticists, bioinformaticians, technicians, bioethicists, and a coordinator. METHODS AND RESULTS: We have implemented whole exome sequencing (WES) with subsequent targeted bioinformatics analysis of gene lists for specific disorders. Clinical cases of heterogeneous Mendelian disorders that could potentially benefit from HTS are presented and discussed during the sessions of the task force. Debate concerning the interpretation of identified variants and the content of the final report constitutes a major part of the task force’s work. Furthermore, issues related to bioethics, genetic counseling, quality control, and reimbursement are also addressed. CONCLUSIONS: This multidisciplinary task force has enabled us to create a platform for regular exchanges between all involved experts in order to deal with the multiple complex issues related to HTS in clinical practice and to continuously improve the diagnostic use of HTS. In addition, this task force was instrumental to formally approve the reimbursement of HTS for molecular diagnosis of Mendelian disorders in Switzerland. |
format | Online Article Text |
id | pubmed-4924303 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49243032016-06-29 Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders Fokstuen, S. Makrythanasis, P. Hammar, E. Guipponi, M. Ranza, E. Varvagiannis, K. Santoni, F. A. Albarca-Aguilera, M. Poleggi, M. E. Couchepin, F. Brockmann, C. Mauron, A. Hurst, S. A. Moret, C. Gehrig, C. Vannier, A. Bevillard, J. Araud, T. Gimelli, S. Stathaki, E. Paoloni-Giacobino, A. Bottani, A. Sloan-Béna, F. Sizonenko, L. D’Amato Mostafavi, M. Hamamy, H. Nouspikel, T. Blouin, J. L. Antonarakis, S. E. Hum Genomics Primary Research BACKGROUND: In order to optimally integrate the use of high-throughput sequencing (HTS) as a tool in clinical diagnostics of likely monogenic disorders, we have created a multidisciplinary “Genome Clinic Task Force” at the University Hospitals of Geneva, which is composed of clinical and molecular geneticists, bioinformaticians, technicians, bioethicists, and a coordinator. METHODS AND RESULTS: We have implemented whole exome sequencing (WES) with subsequent targeted bioinformatics analysis of gene lists for specific disorders. Clinical cases of heterogeneous Mendelian disorders that could potentially benefit from HTS are presented and discussed during the sessions of the task force. Debate concerning the interpretation of identified variants and the content of the final report constitutes a major part of the task force’s work. Furthermore, issues related to bioethics, genetic counseling, quality control, and reimbursement are also addressed. CONCLUSIONS: This multidisciplinary task force has enabled us to create a platform for regular exchanges between all involved experts in order to deal with the multiple complex issues related to HTS in clinical practice and to continuously improve the diagnostic use of HTS. In addition, this task force was instrumental to formally approve the reimbursement of HTS for molecular diagnosis of Mendelian disorders in Switzerland. BioMed Central 2016-06-28 /pmc/articles/PMC4924303/ /pubmed/27353043 http://dx.doi.org/10.1186/s40246-016-0080-4 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Primary Research Fokstuen, S. Makrythanasis, P. Hammar, E. Guipponi, M. Ranza, E. Varvagiannis, K. Santoni, F. A. Albarca-Aguilera, M. Poleggi, M. E. Couchepin, F. Brockmann, C. Mauron, A. Hurst, S. A. Moret, C. Gehrig, C. Vannier, A. Bevillard, J. Araud, T. Gimelli, S. Stathaki, E. Paoloni-Giacobino, A. Bottani, A. Sloan-Béna, F. Sizonenko, L. D’Amato Mostafavi, M. Hamamy, H. Nouspikel, T. Blouin, J. L. Antonarakis, S. E. Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders |
title | Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders |
title_full | Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders |
title_fullStr | Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders |
title_full_unstemmed | Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders |
title_short | Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders |
title_sort | experience of a multidisciplinary task force with exome sequencing for mendelian disorders |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924303/ https://www.ncbi.nlm.nih.gov/pubmed/27353043 http://dx.doi.org/10.1186/s40246-016-0080-4 |
work_keys_str_mv | AT fokstuens experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT makrythanasisp experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT hammare experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT guipponim experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT ranzae experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT varvagiannisk experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT santonifa experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT albarcaaguileram experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT poleggime experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT couchepinf experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT brockmannc experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT maurona experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT hurstsa experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT moretc experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT gehrigc experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT vanniera experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT bevillardj experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT araudt experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT gimellis experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT stathakie experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT paolonigiacobinoa experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT bottania experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT sloanbenaf experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT sizonenkoldamato experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT mostafavim experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT hamamyh experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT nouspikelt experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT blouinjl experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders AT antonarakisse experienceofamultidisciplinarytaskforcewithexomesequencingformendeliandisorders |